共 111 条
[1]
Salvatore SP(2017)Kidney disease in patients with obesity: It is not always obesity-related glomerulopathy alone Obes. Res Clin. Pract. 11 597-606
[2]
Chevalier JM(2009)Role of altered insulin signaling pathways in the pathogenesis of podocyte malfunction and microalbuminuria Curr. Opin. Nephrol. Hypertens. 18 539-545
[3]
Kuo SF(2007)Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study J. Am. Soc. Nephrol. 18 235-243
[4]
Audia PF(2007)Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial J. Am. Soc. Nephrol. 18 1540-1546
[5]
Seshan SV(2004)Body mass index and the risk of development of end-stage renal disease in a screened cohort Kidney Int. 65 1870-1876
[6]
Jauregui A(2006)Body mass index and risk for end-stage renal disease Ann. Intern. Med. 144 21-28
[7]
Mintz DH(2011)Obesity related kidney disease Curr. Diabetes Rev. 7 41-49
[8]
Mundel P(2001)Obesity-related glomerulopathy: an emerging epidemic Kidney Int. 59 1498-1509
[9]
Fornoni A(2007)Central obesity is an independent risk factor for albuminuria in nondiabetic South Asian subjects Diabetes Care 30 1840-1844
[10]
de Boer IH(2013)Association of a reduction in central obesity and phosphorus intake with changes in urinary albumin excretion: the PREMIER study Am. J. Kidney Dis. 62 900-907